Lower Limb Spasticity After Stroke Clinical Trial
Official title:
Comparison of Clinical Efficacy of Botulinum Neurotoxin Type A1 and A2 for Post-Stroke Lower Limb Spasticity: Phase 2/3
To test the safety and efficacy of a new generation botulinum toxin preparation A2NTX for
treating stroke patients with lower limb spasticity.
- we study the degree of spasticity in the ankle and knee joints, and walking speed in 30
patients with stroke before and after injecting 300 units of BOTOX or A2NTX in a blinded
manner as for the patient, the physician, and the examiner.
- we also assess the safety of A2NTX and compare it to that of BOTOX.
n/a